Who owns Augustine Therapeutics?

Augustine Therapeutics is currently owned by Jeito Capital, through Jeito II, since 2025.

When did Jeito Capital acquire Augustine Therapeutics?

Jeito Capital acquired Augustine Therapeutics in 2025 (active for 1 year).

Home/Companies/Biotech/Augustine Therapeutics

Augustine Therapeutics

Biotech·

Belgium·Active·1yr hold

Augustine Therapeutics is a healthcare company, headquartered in France.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Most recent investor

Jeito Capital

2 ownership periods

Key facts

HQFrance

SectorHealthcare

Leuven-based biotech developing HDAC6 selective inhibitors for neuromuscular disorders; Jeito Capital backed in 2025 as Fund II investment.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito II

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings